Cronos CRON
NASDAQ CRON
$3.22 -0.07 (-2.13%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cronos (CRON) Gross Margin (2018 - 2026)

Cronos (CRON) posted quarterly Gross Margin of 42.36% for Q1 2026, down 10016.0% year-over-year from N/an in Q1 2025, and up 16.53% quarter-over-quarter from 36.35% in Q4 2025.

Cronos (CRON) Gross Margin (2018 - 2026) Analysis & Trends

Cronos' Gross Margin history runs 9 years deep, the most recent figure standing at 42.36% for Q1 2026.

  • In Q1 2026, Gross Margin fell 10016.0% year-over-year to 42.36%; the TTM figure through Mar 2026 stood at 45.64% (down 1414.0% YoY), while the FY2025 annual figure was 42.81%, up 2139.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 42.36%, up from 36.35% in the prior quarter.
  • The five-year high for Gross Margin was 142.53% in Q1 2025, with the low at 357.37% in Q4 2024.
  • The 5-year median for Gross Margin is 17.73% (2024), against an average of 13.68%.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin slumped 36537 bps in 2024, then surged 39373 bps in 2025.
  • Cronos' Gross Margin stood at 2.99% in 2022, then surged by 368 bps to 8.0% in 2023, then plunged by 4568 bps to 357.37% in 2024, then soared by 110 bps to 36.35% in 2025, then gained by 17 bps to 42.36% in 2026.
  • Business Quant data shows CRON's Gross Margin at 42.36% in Q1 2026, 36.35% in Q4 2025, and 37.54% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 51.98%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 42.63%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 66.66%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 87.30%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 38.77%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 97.58%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 58.33%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Cronos 1.20 Bn 407.87 Mn 28.45 Mn 40.30%

Historic Data

Download Data
DateValue
Jun 30, 2026 40.30%
Mar 31, 2026 42.36%
Dec 31, 2025 36.35%
Sep 30, 2025 37.54%
Jun 30, 2025 134.33%
Mar 31, 2025 142.53%
Dec 31, 2024 -357.37%
Sep 30, 2024 29.29%
Jun 30, 2024 16.28%
Mar 31, 2024 17.73%
Dec 31, 2023 8.00%
Sep 30, 2023 16.00%
Jun 30, 2023 12.01%
Mar 31, 2023 41.46%
Dec 31, 2022 -2.99%
Sep 30, 2022 15.40%
Jun 30, 2022 15.95%
Mar 31, 2022 27.67%
Dec 31, 2021 29.12%
Sep 30, 2021 -17.45%